Trial Profile
Linezolid in the treatment of subjects with complicated skin and soft tissue infections proven to be due to methicillin-resistant Staphylococcus aureus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Linezolid (Primary) ; Aztreonam; Metronidazole; Vancomycin
- Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 Jun 2019 Trial has been completed in Ireland, according to European Clinical Trials Database record.
- 07 Aug 2012 Actual patient number changed from 1052 to 1077 as reported by ClinicalTrials.gov record.
- 12 Sep 2009 Results of a post hoc analysis were presented at ICAAC 2009.